Expert Opinion on Therapeutic Targets

Metalloproteases as potential therapeutic targets in arthritis treatment
pp. 1-18(18)
Authors: Rowan, Andrew D; Litherland, Gary J; Hui, Wang; Milner, Jennifer M

Targeting ischemic brain injury with intravenous immunoglobulin
pp. 19-29(11)
Authors: Arumugam, Thiruma V; Selvaraj, Pradeep K; Woodruff, Trent M; Mattson, Mark P

Superior cervical ganglion-10 protein as a molecular effector of c-Jun N-terminal kinase 1: implications for the therapeutic targeting of Jun N-terminal kinase in nerve regeneration
pp. 31-43(13)
Authors: Westerlund, Nina; Zdrojewska, Justyna; Courtney, Michael J; Coffey, Eleanor T

An update on the development of drugs for neuropsychiatric disorders: focusing on the σ₁ receptor ligand
pp. 45-58(14)
Authors: Hayashi, Teruo; Su, Tsung-Ping

Targeting synuclein-γ to counteract drug resistance in cancer
pp. 59-68(10)
Authors: Singh, Vinay K; Jia, Zongchao

Aurora kinase inhibitors: identification and preclinical validation of their biomarkers
pp. 69-80(12)
Authors: Carpinelli, Patrizia; Moll, Jürgen

Topiramate and Type 2 diabetes: an old wine in a new bottle
pp. 81-90(10)
Authors: Khanna, Vivek; Arumugam, Surendar; Roy, Subhasis; Mittra, Shivani; Bansal, Vinay S

AMP activated protein kinase: a next generation target for total metabolic control
pp. 91-100(10)
Author: Misra, Parimal

Privileged scaffolds targeting reverse-turn and helix recognition
pp. 101-114(14)
Authors: Che, Ye; Marshall, Garland R

Applying small RNA molecules to the directed treatment of human diseases: realizing the potential
pp. 115-127(13)
Authors: Pappas, Todd C; Bader, Andreas G; Andruss, Bernard F; Brown, David; Ford, Lance P